You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

SARS-CoV-2

Test Information
Home / Tests / Healthcare Associated Infections / Xpert C. difficile BT

Xpert® C. difficile BT

Detection of Clostridium difficile in Around 45 Minutes

Xpert<sup>®</sup> <em>C. difficile</em> BT

The Need


C. difficile infections (CDI) have been increasing in incidence and severity, and are associated with an increase in length of hospital stay, costs, morbidity and mortality.2

  • Highly virulent (027-NAP1-BI) strains have caused outbreaks of severe disease in Europe and North America3
  • Binary toxin (BT) may be important because of:
    • Links to both disease severity and outcome4
    • Strains such as 033 are positive only for binary toxin and not toxins A and B, yet have caused CDI5,6
       

Incremental costs associated with C. difficile infection7

 

The Solution


CDI has become a substantive and growing burden in hospitalised patients prompting the need for earlier and accurate detection.

Xpert® C. difficile BT enables:

  • Fast identification of toxin-producing C. difficile in around 45 minutes
  • Broad coverage with multiple targets, including: toxin B (tcdB), binary toxin (cdtA), and the tcdC deletion at base 117 associated with the ribotype 027 strain, a predictor of severe CDI and mortality8
  • Optimised and prompt administering of therapy to support improved patient outcomes9
  • Timely infection control initiatives to reduce the spread of infection10
  • Laboratory efficiencies with on-demand workflows requiring minimal hands-on time and no repeat testing1,11

The Impact


On-demand answers, anywhere and anytime your patients need care

(1) Casari E, et al. Reducing rates of Clostridium difficile infection by switching to a stand-alone NAAT with clear sampling criteria. Antimicrob Resist Infect Control. 2018 Mar;7(40).
(2) European Hospital and Healthcare Federation (HOPE). CDI Europe Report, 2013: Clostridium difficile infection in Europe. FDX/12/0082/EU.
(3) Marujo V, et al. The largely unnoticed spread of Clostridioides difficile PCR ribotype 027 in Germany after 2010. IPIP. 2020 Dec;2(4):100102.
(4) Stewart D, et al. Predicting recurrence of C. difficile colitis using bacterial virulence factors: binary toxin is the key. J Gastrointest Surg. 2013 Jan;17(1):118-24.
(5) Eckert C, et al. Prevalence and pathogenicity of binary toxin-positive C. difficile strains that do not produce toxins A and B. New Microbes New Infect. 2014 Nov;8(3):12-7.
(6) Androga G, et al. Evaluation of the Cepheid Xpert C. difficile/Epi and meridian bioscience illumigene C. difficile assays for detecting Clostridium difficile ribotype 033 strains. J Clin Microbiol. 2015 Mar;53(3):973-5.
(7) Tresman R & Goldenberg S. Healthcare resource use and attributable cost of Clostridium difficile infection: a micro-costing analysis comparing first and recurrent episodes. J Antimicrob Chemother. 2018 Oct;73(10):2851-2855.
(8) Rao K, et al. C. difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality. Clin Infect Dis. 2015 Jul 15;61(2):233-41.
(9) Peppard W, et al. Implementation of polymerase chain reaction to rule out C. difficile infection is associated with reduced empiric antibiotic duration of therapy. Hosp Pharm. 2014 Jul;49(7):693-43.
(10) Schroeder L, et al. Economic evaluation of laboratory testing strategies for hospital-associated Clostridium difficile infection. JCM. 2014 Feb;52(2):489.
(11) Following C. difficile sampling guidance detailed in: McDonald L, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 Apr;66(7):e1–e48.CATALOG INFORMATIONXpert® C. difficile BT10 testsGXCDIFFBT-CE-10

Ordering Info


Xpert® C. difficile BT

Number of Tests: 10

Catalog #: GXCDIFFICILE-CE-10

Xpert® C. difficile BT

Number per Pack: 120

Catalog #: SDPS-120

Xpert® C. difficile BT

Number of Swabs: 50

Catalog #: 900-0370
Back to Top